Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer
To access this article, please choose from the options below
PII: S0169-5002(08)00059-7
doi:10.1016/j.lungcan.2008.02.001
© 2008 Elsevier Ireland Ltd. All rights reserved.
